These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 33222150)

  • 1. ABO haemolytic disease of the fetus and newborn in a blood group AB neonate due to maternal immunoglobulin G anti-A and anti-B antibodies.
    Bu X; Sun P; Wan Y
    Br J Haematol; 2021 Feb; 192(3):416. PubMed ID: 33222150
    [No Abstract]   [Full Text] [Related]  

  • 2. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.
    Ziprin JH; Payne E; Hamidi L; Roberts I; Regan F
    Transfus Med; 2005 Feb; 15(1):57-60. PubMed ID: 15713130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women].
    Yang SM; Wu QY; Luo HQ; Lan JC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):875-7. PubMed ID: 16277862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease.
    Das S; Shastry S; Chakravarthy PK; Baliga PB
    Transfus Med; 2021 Feb; 31(1):30-35. PubMed ID: 32969542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of high risk pregnancies with relation to ABO haemolytic disease of newborn.
    Usha KK; Sulochana PV
    Indian J Pediatr; 1998; 65(6):863-5. PubMed ID: 10773951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion.
    Metcalf RA; Khan J; Andrews J; Mayock D; Billimoria Z; Pagano MB
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):632-634. PubMed ID: 30044350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-haemolytic disease of the newborn (ABO-HDN): factors influencing its severity and incidence in Venezuela.
    Cariani L; Romano EL; Martínez N; Montaño R; Suarez G; Ruiz I; Soyano A
    J Trop Pediatr; 1995 Feb; 41(1):14-21. PubMed ID: 7723123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABO incompatibility--when is antenatal testing indicated?
    Beischer NA
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):315. PubMed ID: 9325514
    [No Abstract]   [Full Text] [Related]  

  • 10. [Icterus gravis in ABO incompatibility and bilirubin coupling disorders].
    Stur O
    Wien Med Wochenschr; 1970 May; 120(22):400-1. PubMed ID: 5534805
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of the severity of ABO haemolytic disease of the newborn by cord blood tests.
    Whyte J; Graham H
    Acta Paediatr Scand; 1981 Mar; 70(2):217-22. PubMed ID: 7195139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis.
    Li P; Pang LH; Liang HF; Chen HY; Fan XJ
    Fetal Pediatr Pathol; 2015; 34(6):341-50. PubMed ID: 26359685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO hemolytic disease.
    Cook LN
    Clin Obstet Gynecol; 1982 Jun; 25(2):333-9. PubMed ID: 7105509
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother.
    Drabik-Clary K; Reddy VV; Benjamin WH; Boctor FN
    Ann Clin Lab Sci; 2006; 36(2):205-7. PubMed ID: 16682519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of ABO haemolytic disease of the fetus and newborn in neonates born to group O mothers.
    Talwar M; Jain A; Sharma RR; Kumar P; Saha SC; Singh L
    Vox Sang; 2022 Sep; 117(9):1112-1120. PubMed ID: 35667836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility.
    Awad HA; Tantawy AA; El-Farrash RA; Ismail EA; Youssif NM
    Blood Transfus; 2014 Apr; 12(2):250-9. PubMed ID: 24333075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental permeability in the human for anti-A and anti-B isoantibodies. Clinical implications.
    FREDA VJ; CARTER BA
    Am J Obstet Gynecol; 1962 Nov; 84():1351-67. PubMed ID: 13959385
    [No Abstract]   [Full Text] [Related]  

  • 18. A detailed serological study on the prediction and diagnosis of ABO haemolytic disease of the newborn (ABO HD).
    Voak D; Bowley CC
    Vox Sang; 1969 Nov; 17(5):321-48. PubMed ID: 5308005
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemolytic disease of fetus and newborn caused by ABO antibodies in a cisAB offspring.
    Deng ZH; Seltsam A; Ye YW; Yu Q; Li Q; Su YQ; Liang YL; Zang H
    Transfus Apher Sci; 2008 Oct; 39(2):123-8. PubMed ID: 18793871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple method for the prediction of ABO incompatibility using Sephadex A-50. Prediction of ABO incompatibility.
    Graham H; Morrison M; MacAndrew R
    Vox Sang; 1975; 29(5):371-7. PubMed ID: 1199025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.